Evolution Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$211K Sell
229
-72
-24% -$73K 0.02% 162
2025
Q4
$323K Sell
301
-11
-4% -$10.5K 0.03% 131
2025
Q3
$238K Buy
312
+3
+1% +$2.23K 0.03% 151
2025
Q2
$241K Buy
309
+10
+3% +$7.77K 0.04% 152
2025
Q1
$247K Sell
299
-25
-8% -$20.8K 0.04% 129
2024
Q4
$250K Buy
324
+9
+3% +$7.45K 0.04% 120
2024
Q3
$278K Sell
315
-2
-0.6% -$1.8K 0.05% 108
2024
Q2
$287K Buy
317
+14
+5% +$11.2K 0.06% 109
2024
Q1
$236K Buy
+303
New +$216K 0.05% 119
2021
Q4
Sell
-589
Closed -$136K 418
2021
Q3
$136K Sell
589
-92
-14% -$22.7K 0.03% 133
2021
Q2
$156K Buy
681
+9
+1% +$1.81K 0.03% 140
2021
Q1
$126K Buy
672
+243
+57% +$47.5K 0.03% 139
2020
Q4
$72K Sell
429
-114
-21% -$17K 0.02% 159
2020
Q3
$80K Buy
543
+99
+22% +$15.3K 0.02% 156
2020
Q2
$73K Buy
444
+402
+957% +$61.7K 0.02% 124
2020
Q1
$6K Sell
42
-53
-56% -$7.28K ﹤0.01% 241
2019
Q4
$12K Sell
95
-98
-51% -$11.4K ﹤0.01% 271
2019
Q3
$22K Buy
193
+64
+50% +$7.13K 0.01% 86
2019
Q2
$14K Buy
+129
New +$15.2K 0.01% 152

Other funds holding LLY

Evolution Wealth Advisors's LLY Position: Q1 2026 in Review

Evolution Wealth Advisors reduced its Eli Lilly (LLY) stake by 24% in Q1 2026, selling an estimated $73K and leaving 229 shares worth $211K. The position accounts for 0.02% of the portfolio, ranked #162.

Evolution Wealth Advisors first reported a position in LLY in Q2 2019 and has held it in 19 quarters since. The position peaked at $323K in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Evolution Wealth Advisors held 229 shares of Eli Lilly worth $211K as of Q1 2026.
  • Evolution Wealth Advisors sold 72 Eli Lilly shares in Q1 2026, an estimated $73K.
  • Eli Lilly made up 0.02% of Evolution Wealth Advisors's portfolio in Q1 2026, its #162 holding.
  • Evolution Wealth Advisors first reported a position in Eli Lilly in Q2 2019 and has held it in 19 quarters since.
  • Evolution Wealth Advisors's Eli Lilly position peaked at $323K in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Evolution Wealth Advisors's 13F filing for Q1 2026, filed 8 May 2026.